Mustang Bio Inc (MBIO) — Cash Flow-to-Debt Ratio
Mustang Bio Inc (MBIO) has a Cash Flow-to-Debt Ratio of -0.13x as of March 2026, meaning its operating cash flow of $-1.01 Million could theoretically repay 0% of its total liabilities ($7.99 Million) in one year. See Mustang Bio Inc (MBIO) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mustang Bio Inc Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Mustang Bio Inc across 11 annual periods. Also explore MBIO net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Mustang Bio Inc (2015–2025)
Year-by-year debt coverage analysis for Mustang Bio Inc. For market capitalisation and broader financial context, see MBIO company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.65x | $-5.26 Million | $8.06 Million | ▲ +24.6% |
| 2024 | -0.87x | $-11.41 Million | $13.18 Million | ▲ +69.2% |
| 2023 | -2.81x | $-49.48 Million | $17.62 Million | ▼ -99.2% |
| 2022 | -1.41x | $-65.07 Million | $46.15 Million | ▲ +66.5% |
| 2021 | -4.20x | $-53.67 Million | $12.77 Million | ▼ -29.1% |
| 2020 | -3.26x | $-37.32 Million | $11.46 Million | ▼ -111.2% |
| 2019 | -1.54x | $-33.58 Million | $21.79 Million | ▲ +49.1% |
| 2018 | -3.03x | $-19.24 Million | $6.36 Million | ▲ +14.4% |
| 2017 | -3.54x | $-12.95 Million | $3.66 Million | ▼ -176.1% |
| 2016 | -1.28x | $-4.13 Million | $3.22 Million | ▼ -236.7% |
| 2015 | -0.38x | $-1.57 Million | $4.13 Million | — |